Royalty Pharma plcRPRXNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank20
3Y CAGR-3.2%
5Y CAGR-5.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-3.2%/yr
vs -3.1%/yr prior
5Y CAGR
-5.2%/yr
Consistent
Acceleration
-0.1pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.02 | +39.6% |
| 2024 | 5.03 | -5.9% |
| 2023 | 5.34 | -31.0% |
| 2022 | 7.74 | +7.2% |
| 2021 | 7.22 | -21.1% |
| 2020 | 9.15 | +5.4% |
| 2019 | 8.69 | -1.1% |
| 2018 | 8.78 | -11.0% |
| 2017 | 9.86 | -31.5% |
| 2016 | 14.39 | - |